<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00698698</url>
  </required_header>
  <id_info>
    <org_study_id>Tear proteins</org_study_id>
    <nct_id>NCT00698698</nct_id>
  </id_info>
  <brief_title>Study on Tear Proteins in Diabetic Retinopathy of Type 2 Diabetics</brief_title>
  <official_title>Tear Proteins and Diabetic Retinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dow University of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dow University of Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes mellitus is becoming a global epidemic. There is a need to devise a non invasive
      method for detection of diabetes and its related complication. Tear proteins are easy to
      collect causing no harm to a patient and different studies indicate that tear proteins of
      diabetic patients are significantly different from non diabetic population. This difference
      in the composition of tear proteins become more pronounced with advancement of diabetic
      retinopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes mellitus causes a significant alteration in tear proteins. If we analyze tear
      proteins by means of electrophoresis, HPLC, and mass spectroscopy.

      We can find different type of tear proteins in different grades of diabetic retinopathy these
      biomarkers can help in mass screening , diagnosis and management of diabetic population.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Non diabetic</arm_group_label>
    <description>Normal age and sex matched population</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grade 1</arm_group_label>
    <description>Diabetic population with no retinopathy or Mild non proliferative diabetic retinopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grade 2</arm_group_label>
    <description>Moderate non proliferative diabetic retinopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grade 3</arm_group_label>
    <description>Severe non proliferative diabetic retinopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grade 4</arm_group_label>
    <description>Proliferative diabetic retinopathy and advanced diabetic eye disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        diabetic population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diabetic patients with type 2 diabetes

          -  age above 30

          -  willing to participate

        Exclusion Criteria:

          -  ocular surface disorders.

          -  collagen vascular diseases

          -  Limbal hyperemia

          -  previous ocular surgery

          -  creatinine level above 1.0

          -  liver diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Jamshed Ahmed, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dow University of Health Sciences Pakistan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dow University of Health Sciences</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>75500</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2008</study_first_submitted>
  <study_first_submitted_qc>June 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2008</study_first_posted>
  <last_update_submitted>January 30, 2009</last_update_submitted>
  <last_update_submitted_qc>January 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr.Jamshed Ahmed Assistant Professor</name_title>
    <organization>Dow university of Health Sciences Karachi Pakistan</organization>
  </responsible_party>
  <keyword>tear proteins</keyword>
  <keyword>diabetic retinopathy</keyword>
  <keyword>HPLC</keyword>
  <keyword>Mass spectroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

